about
Magnesium sulphate for women at term for neuroprotection of the fetusMagnesium sulphate for women at term for neuroprotection of the fetusShould we allow organ donation euthanasia? Alternatives for maximizing the number and quality of organs for transplantation.Australian attitudes to early and late abortion.A life worth giving? The threshold for permissible withdrawal of life support from disabled newborn infants.Balancing obligations: should written information about life-sustaining treatment be neutral?The Intensive Care Lifeboat: a survey of lay attitudes to rationing dilemmas in neonatal intensive care.Awake upper airway obstruction in children with spastic quadriplegic cerebral palsy.Is it in the best interests of an intellectually disabled infant to die?Death in the neonatal intensive care unit: changing patterns of end of life care over two decades.Conscientious Non-objection in Intensive Care.Perinatal management of trisomy 18: a survey of obstetricians in Australia, New Zealand and the UKGestational ageism.Question 1 * do feeding practices during transfusion influence the risk of developing necrotising enterocolitis in preterm infants?Neuroimaging and the withdrawal of life-sustaining treatment from patients in vegetative state.The window of opportunity: decision theory and the timing of prognostic tests for newborn infants.A costly separation between withdrawing and withholding treatment in intensive care.Is it better to be minimally conscious than vegetative?The luck of the draw: physician-related variability in end-of-life decision-making in intensive care.Zika, contraception and the non-identity problem.Shades of grey.Death in the Netherlands: evidence and argument.Should long-term ventilation be offered in severe spinal muscular atrophy.The "research misconception" and the SUPPORT trial: toward evidence-based consensus.Settling for second best: when should doctors agree to parental demands for suboptimal medical treatment?Futile treatment: the ethicist's perspective.Three myths in end-of-life care.Bedside algorithms for managing desaturation in ventilated preterm infants: a randomised crossover trial.A case of consent.Making the cut: analytical and empirical bioethics.Expensive care? Resource-based thresholds for potentially inappropriate treatment in intensive care.Hypothermia: a neuroprotective therapy for neonatal hypoxic-ischemic encephalopathy.Cost-equivalence and Pluralism in Publicly-funded Health-care Systems.Ethical and practical issues relating to the global use of therapeutic hypothermia for perinatal asphyxial encephalopathy.The self-fulfilling prophecy in intensive care.Beyond the borderline: outcomes for inborn infants born at ≤500 grams.Trade-offs in suffering and wellbeing: the utilitarian argument for primate stroke research.Consequentialism and the death penalty.Ethical challenges in the use of therapeutic hypothermia in Indian neonatal units.Authors' response to: Fatally flawed?
P50
Q24200779-79B71C25-A2FD-4103-91D8-2770B6FE058DQ24234006-BD7E5D57-B954-4B3C-92C2-2F580615A43CQ34114666-70D6B0FC-DF9A-4A90-B0ED-41A660CDDF74Q34125161-32731628-8F57-4087-A97E-1B1B4E68270FQ34863631-FE946407-A6CF-4C1C-A42A-2175918CEFF6Q35134428-45AB94F3-94A7-4DEB-9281-23D84B40B840Q36184790-6E0A7B8F-3F59-40A3-93F2-B283CD979B43Q36399955-2EB1E051-68F8-4C71-989B-5172A797DC52Q36927483-2C4DCB1B-2ADF-42DA-BA16-10F0133D0FA1Q37168204-4A071F47-994B-4976-B869-8DF2E3520A0FQ37542121-574FE10C-47EF-4AEE-84A4-EFC813207481Q37658479-88EF4213-4498-4948-BF27-1ECD2C0F8CE1Q38016106-A48C3B7D-8011-4ABC-A0C3-268CE4DD8DD9Q38098976-59E450A6-0170-423A-82FE-54451315FCCBQ39349215-BF119347-BE00-4E6B-BDCD-0C81E25061AAQ39943277-F2CC1426-F96C-435A-A7B7-B1352E4C4ABCQ42481570-309CD13C-DE73-4A7C-9FFA-0F295B00C8D8Q43411062-C7D5B97A-737A-4832-9020-7C49451C6E6EQ43428251-66D714E0-DFBA-46AD-AE63-6A1250B43438Q44169811-EF070C87-F74F-4A04-8033-6E0DA09F9BE7Q44174085-AE6ABFBA-2BF9-4061-9921-537E97EC9FBDQ44362477-346AE015-8E82-4371-A012-6855F6BFABBCQ45789474-96CDACC7-CCCB-4BA1-99CB-38845B4A7873Q45894502-7012D9B9-6731-4D77-8BA4-93921A086ECFQ45945966-4B2DE348-3290-4A02-AE6D-8C06D74FE123Q46345146-3116E06C-5380-4CDD-9D80-06930B8FC633Q47187462-4B3913D4-5833-4D0B-95B9-8F3575308F17Q47192054-FA8CB727-02D8-46D6-A72A-071361C65FFCQ48067711-CD90960B-44C1-4901-929B-EBE68F706231Q48068273-52728671-39C4-4ED8-8DC7-5A7CD01EC74EQ48212224-9422EECC-5854-4410-9122-A76D695BDBC0Q48288721-CB9C8883-3C55-4253-A21C-845963F38686Q48375575-3B0D281E-F3C5-47AE-86BD-F20BB99CDB9DQ48765109-1B967BF8-F837-4B96-823C-C86FEE661F95Q48946344-A74C8CCB-8030-47FB-820F-02075A3B7B0EQ50688471-B96BFBD6-A75F-4394-88D3-0D5DE1858D6BQ50747512-2E9AD710-AACA-436D-A7A9-513E9E96F4CAQ50769393-380617B6-9EC6-487A-8A34-0691C7BFB1C7Q51692804-928775B6-1036-4286-932D-CB1575B4441FQ52951339-22441635-A92D-46E1-9143-86EEFC463CE5
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Dominic Wilkinson
@ast
Dominic Wilkinson
@en
Dominic Wilkinson
@es
Dominic Wilkinson
@nl
Dominic Wilkinson
@sl
type
label
Dominic Wilkinson
@ast
Dominic Wilkinson
@en
Dominic Wilkinson
@es
Dominic Wilkinson
@nl
Dominic Wilkinson
@sl
prefLabel
Dominic Wilkinson
@ast
Dominic Wilkinson
@en
Dominic Wilkinson
@es
Dominic Wilkinson
@nl
Dominic Wilkinson
@sl
P106
P31
P3762
P496
0000-0003-3958-8633